Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and efficacy of elagolix for heavy menstrual bleeding linked to uterine fibroids in premenopausal women has completed with posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Elagolix (elagolix)

Snippet

Sponsor: AbbVie | Conditions: Uterine Fibroids | Phase 4 | Status: COMPLETED | Results posted: 2022-03-31